- Introduction to the current microbiome investment landscape and what direction investment is heading in over the next few years.
- Highlighting what investors need to see from emerging companies, how are CSB evaluating companies.
- How should microbiome companies adapt to trends and what should data packages contain.
Sou Miyake, Director of Investment & Business Development, Corundum Systems Biology
Speaker(s):
![](https://kisacoresearch.com/sites/default/files/styles/panopoly_image_square/public/speakers/sou_miyake_0.jpg?itok=szjUEqNV&c=f3fda9e51444abb4749dbad22fdc292b)
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology